Article Abstract

Prof. Hiroyuki Nakamura: accelerator-based BNCT will be chosen as a primary therapy for early stage cancer

Authors: Tan-Lun Yu


The 18th International Congress on Neutron Capture Therapy was held successfully at the Chang Yung-Fa International Convention Center in Taipei, Taiwan from October 28th to November 2nd, 2018. The theme of the 18th Congress is “Precision Therapy, Beautiful Tomorrow—We Here, We Care”. This congress gathered international clinicians and researchers from industry and academia to feature their findings and generate new thoughts and discoveries related to neutron capture therapy. The key areas included the latest development in accelerator-based neutron sources, the next generation of boron-10 delivery agents, as well as the latest results in chemical, biological and clinical research.